CML 2 Flashcards

1
Q

what is CML

A

stem cell disease w excess myeloid cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

clin molecular lab questions

A

can disorder be defined? pose serious health prob? is there treatment? is there biomarker to assess? easy to measure? correlation to disease?

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

what % survive 5 years

A

67%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

visualize xsomes by karyotyping

A

culture in growth medium, incubate for 2-3 days, add microtubule inhibitor to stop mitosis in metaphase, move cells to tube & centrifuge to conc in layers, transfer to tube (w fixative), stain to enhance xsomes, ID/photograph xsomes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

karyotyping for diagnosis pros

A

gold standard, can ID variants of translocatuon, quantify # cells w translocation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

kartyotyping cons

A

need viable dividing cells, expensive, labor intensive, need analyzing expertise, low sensitivity , need invasive test

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

sensitivity low to high

A

karyotyping, fish, pcr, nested pcr

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

specificity

A

good for karyotyping, fish, pcr, not nested pcr

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

FISH

A

denature dna, add hybridization probes (flor labled), expose to UV light to get signal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

what size dna for FISH

A

400-500 kb … span large areas of genome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

FISH for diagnosis pros

A

quantitative, easy to interpret, sensitive to use PB, works for interphase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

FISH cons

A

expensive, time consuming, need enough cells to analyze

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

PCR diagnosis pros

A

sensitive economical, use BM or PB, rapid, doesn’t require dividing cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

how sensitive is PCR

A

1/10k to 100k

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

PCR diagnosis cons

A

need isolate RNA (unstable), may miss some rare breakpts (in exons)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

BCR ABL colors

A

bcr - red, abl - green, fusion - yellow

17
Q

how PCR works

A

design fwd/reverse primers. fusion gene gives product

18
Q

ABL breakpt region

A

intron bw exon 1, 2

19
Q

pcr starts w rna or dna

20
Q

small # of pcr primer sets can amplify what

A

multiple versions of fusion gene

21
Q

pcr output is easy to read? must include what

A

easy to read output. must include internal PCR control to differentiate bw neg & failed result

22
Q

nested pcr test sensitivity for translocation

A

1 molecule in 10 000 k (rlly high, not great when detect transcrip at low levels which happen all the time)

23
Q

specific amplification of target dna involves

A

using product from 1st pcr round as input for 2nd. 1st set primers (outer). 2nd set primers (inner)

24
Q

qualitative essay

A

yes or no. for initial diagnosis.

25
quantitative
info about amt of biomarker. need after treatment to track relative amt of bcr/abl
26
QRT-PCR
polymerization , strand displacement, cleavage , polymerization complete
27
qrt-pcr polymerization involves
fwd, reverse primer. probe w reporter, quencher. cleave reporter so it flors, show # copies pcr
28
reporter shows up more
at later cycles & as you further dilute it
29
decr in bcr-abl gene transcript (biomarker) levels show
decr in cytogenetic response, correlating to assay sensitivity
30
cytogenetic vs molecular assays
molecular assays more sensitive, cytogenetic = less
31
recurrence of disease after initial response assoc w
extra mutations in orig biomarker (not just fusion, but becomes resistant to imatinib)
32
why use other drugs after treatment
to decr biomarkers again as tumour still evolving
33
diagnostic test for CML
detect philadelphia xsome
34
diagnostic testing evolves as
muchs of resistance becomes clear... 1 mutation but at diff breakpts so it still happens in diff ways